N4P has provided an update on its Nuvec® optimisation programme and proof of concept work involving COVID-19. Interestingly, delays imposed by the Pandemic lockdown presented an opportunity for the Group
N4P has provided an update on its Nuvec® optimisation programme and proof of concept work involving COVID-19. Interestingly, delays imposed by the Pandemic lockdown presented an opportunity for the Group
Avacta has announced that collaborative work with the Centre for Virus Research at the University of Glasgow.
Avacta has announced that the BAMSTM diagnostic test for the COVID-19 infection being developed with its partner Adeptrix (Beverly MA, USA).
Avacta has announced its second partnership to exploit the recently generated Affimer binders to the SARS-COV-2 virus in a high-throughput COVID-19 antigen test.
MOD Resources (ASX/LSE: MOD, Market Capitalisation US$50 million)